Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01752920
Title Phase 1 Dose Escalation Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors ArQule
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA

Facility Status City State Zip Country Details
Scottsdale Healthcare Research Institute Scottsdale Arizona 85258 United States Details
Emory University, Winship Cancer Institute Atlanta Georgia 30322 United States Details
Karmanos Cancer Institute, Detroit Detroit Michigan 48201 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Montefiore-Einstein Center for Cancer Care Bronx New York 10467 United States Details
University of Pennsylvania Hospital Philadelphia Pennsylvania 19104 United States Details
START - South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
University of Washington Seattle Washington 98109 United States Details
Istituto Clinico Humanitas Milan 20089 Italy Details
Istituto Nazionale Tumori (National Cancer Institute) Milan 20133 Italy Details
Instituto Oncologico Veneto, IRCCS Padova 35128 Italy Details
Azienda Ospedaliero-Universitaria Pisana - U.O. Oncologia Medica 2 Univ. Pisa 56126 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field